response was measured by cavernosal nerve stimulation. The relaxant and contractile responses of CC were obtained from in vitro studies. Western blotting and immunohistochemistry were used to evaluate protein expression and localization of neuronal nitric oxide synthase (NOS), endothelial NOS, CSE, CBS, oxidative stress (inducible NOS and nuclear factor kappa B), hypoxia (hypoxia-inducible factor-1a) and fibrosis (transforming growth factor beta 1) markers. The relative area of smooth muscle to collagen using Masson trichrome staining was determined.
response was measured by cavernosal nerve stimulation. The relaxant and contractile responses of CC were obtained from in vitro studies. Western blotting and immunohistochemistry were used to evaluate protein expression and localization of neuronal nitric oxide synthase (NOS), endothelial NOS, CSE, CBS, oxidative stress (inducible NOS and nuclear factor kappa B), hypoxia (hypoxia-inducible factor-1a) and fibrosis (transforming growth factor beta 1) markers. The relative area of smooth muscle to collagen using Masson trichrome staining was determined.
RESULTS: Our data were reported in Table 1 . Combined treatment completely restored enhanced bladder weight, decreased in vivo erectile responses, in vitro electrical field stimulation (EFS)-mediated and endothelium-dependent acetylcholine (ACh)-induced relaxation of CC in the PBOO group, while partial improvement with monotherapy. Contractile responses of CC in obstructed rats were lower than in control rats, which were increased in all treatments groups (Table 1) . The combined treatment modulated alteration of protein expressions and decreased ratio of smooth muscle to collagen in obstructed rats.
CONCLUSIONS: We firstly indicated that successful combination with H 2 S donor and PDE5i therapy provided the recovery of erectile function, the progression of ischemia-related functional and morphological penile changes in obstruction. H 2 S and NO most probably may have a synergistic effect on the structure of penile tissue and molecular regulation of erectile function, and be beneficial for improving clinical outcomes in men with ED and BPH/LUTS. 
MP43-13 ENDOPEPTIDASE INHIBITION -A POTENTIAL NEW OPTION TO TARGET ERECTILE DYSFUNCTION? AN IN VITRO STUDY
Pejman Shahin, Stefan € uckert*, Hannover, Germany; Harrina Rahardjo, Jakarta, Indonesia; Andreas Bannowsky, Rendsburg, Germany; Markus Kuczyk, Hannover, Germany INTRODUCTION AND OBJECTIVES: It has been established that non-adrenergic, non-cholinergic signaling molecules, such as Ctype natriuretic peptide (CNP), vasoactive intestinal polypeptide (VIP) and endothelin-1 (ET-1), are involved in the control of male penile erectile tissue (corpus cavernosum ¼ CC). Tissue levels of said peptides are regulated by the activity of endopeptidase enzymes (NEP, hSEP). Theoretically, the inhibition of the degradation of CNP and VIP or the conversion of Big ET-1 into ET-1 in human penile erectile tissue should result in an enhancement of trabecular smooth muscle relaxation and, thus, an improvement in erectile function. It was the aim of the study to elucidate the in vitro effects of the endopeptidase inhibitor KC 12615 on the relaxation of CC induced by CNP or VIP and the contraction mediated by Big ET-1.
METHODS: Using the tissue bath technique, the responses of isolated human CC, challenged by 1 mM norepinephrine, to increasing concentrations of KC-12615 (1 nM -10 mM), CNP and VIP (0.1 nM -1 mM) were investigated. In addition, the effects of CNP, VIP and Big ET-1 (0.1 nM -100 nM) on the isometric tension of the cavernous tissue following pre-exposure (for 20 minutes) to 10 mM of KC 12615 were also evaluated.
RESULTS: While no relaxing effects of KC 12615 were observed, the NE-induced tension of the tissue was dose-dependently reversed by CNP and VIP to 38.7 AE 15.8% and 62.6 AE 13%, respectively, of the initial force generation. Increasing concentrations (0.1 nM -100 nM) of Big ET-1 induced contraction of the CC strips amounting to a final tension of 1200 mg. While pre-exposure to KC 12615 had no effects on the relaxation exerted by CNP and VIP, the contraction induced by 10 nM and 100 nM Big ET-1 was significantly attenuated in the presence of KC 12615 by 35% and 50%, respectively.
CONCLUSIONS: The inhibition of endopeptidase activity can antagonize the contraction of human penile erectile tissue induced by Big ET-1. These findings might be of significance with regard to future pharmacological treatment options for male ED, in particular in certain conditions where a generalized endothelial dysfunction exists (such as diabetes mellitus, systemic vascular sclerosis).
Source of Funding: Abbott Products GmbH

MP43-14 SONIC HEDGEHOG REGULATION OF SPROUTING IN PENILE PROJECTING NEURONS
Ryan Dobbs, Shawn Choe, Elizabeth Kalmanek, Chicago, IL; Daniel Harrington, Houston, TX; Samuel Stupp, Chicago, IL; Kevin McVary, Springfield, IL; Carol Podlasek*, Chicago, IL INTRODUCTION AND OBJECTIVES: Sonic hedgehog (SHH) protein delivered by nanoparticle based peptide amphiphile (PA) nanofiber hydrogel to the cavernous nerve at the time of crush injury (prostatectomy model), is neuroprotective, promotes cavernous nerve (CN) regeneration, and return of erectile function, by an unknown mechanism. Since local conditions influence emergence of axonal sprouts, and SHH is critical to maintain neural-glial interactions, we hypothesize that SHH is a key regulator of regenerative processes taking place at the proximal injury site, including axonal sprouting. We examine this hypothesis, and the effects of aging on sprouting potential, in an in vitro organ culture model. METHODS: The caudal portion of the pelvic ganglia and CN were dissected from adult Sprague Dawley rats (n¼63), and aged (n¼10) rats, and were grown in organ culture 3-5 days. PG/CN were exposed to Affi-Gel beads containing: 1.) SHH protein, 2.) 5e1 or cyclopamine SHH inhibitors, and 3.) SHH protein delivered by PA. PBS, MSA, or DMSO were used as controls. Additional PG/CN underwent CN crush and were exposed to SHH PA in vivo for 4 days with an additional 4 days in culture. Sprouting was quantified by counting the number of growth cones. Immunohistochemistry for GAP43 and nNOS was performed.
RESULTS: SHH promoted abundant and extensive sprouting in uninjured (53%) and crushed (33%) CNs. SHH inhibition decreased sprouting >80%. Sprouting of penile projecting neurons was confirmed with GAP43 and nNOS. Sprouting potential was highest at 2 days after injury. Most robust sprouting was observed with continuous SHH treatment by PA to crushed CN (75%). Once induced with SHH, sprouts continued to grow when SHH was withdrawn. SHH rescued sprouting when not given immediately. Sprouting was reduced in uninjured aged rats and after CN crush, however SHH treatment induced abundant sprouting.
CONCLUSIONS: SHH is a critical regulator of sprouting in uninjured and regenerating CNs. Treatment with SHH protein at the time of CN injury, would be beneficial to enhance sprouting. There is potential for intervention in the regenerative process even after immediate injury. Sprouting is reduced in aged rats, which impacts regenerative potential, and can be rescued with SHH treatment. Understanding how sprouting changes with age is critical for clinical translation.
